Opus Genetics, Inc. (FRA:R3X1)
Germany · Delayed Price · Currency is EUR 1.762
-0.004 (-0.23%)
At close: Jan 6, 2026
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of €114.43 million as of January 9, 2026. Its market cap has increased by 265.89% in one year.
Market Cap
114.43M
Enterprise Value
88.85M
Revenue
12.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.76
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from 17.89M to 114.43M, an increase of 539.76%. That is a compound annual growth rate of 43.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 114.43M | -3.08% |
| Dec 31, 2025 | 118.06M | 225.37% |
| Dec 31, 2024 | 36.29M | -41.14% |
| Dec 29, 2023 | 61.65M | -10.30% |
| Dec 30, 2022 | 68.73M | 21.12% |
| Dec 31, 2021 | 56.74M | -1.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |